TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2071214
log Bayes Factor = 0.0628075
Chromosome 17   position 76,219,591  (GRCh37) Explore rs2071214 on Ensembl!
Variant rs2071214 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
L40.9 Psoriasis, unspecified
0.049 0.951 0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.000 0.954 0.046
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.000 0.954 0.046
K91.4 Colostomy and enterostomy malfunction
0.000 0.956 0.044
R05 Cough
0.044 0.956 0.000
Z80.0 Family history of malignant neoplasm of digestive organs
0.044 0.956 0.000
K91.3 Postoperative intestinal obstruction
0.000 0.958 0.042
K91.0 Vomiting following gastro-intestinal surgery
0.000 0.961 0.039
K91.9 Postprocedural disorder of digestive system, unspecified
0.000 0.964 0.036
K91.1 Postgastric surgery syndromes
0.000 0.964 0.036
K91.2 Postsurgical malabsorption, not elsewhere classified
0.000 0.965 0.035
K91.5 Postcholecystectomy syndrome
0.000 0.969 0.031
L40 Psoriasis
0.031 0.969 0.000
F10.2 Dependence syndrome
0.028 0.972 0.000
L40.0 Psoriasis vulgaris
0.024 0.976 0.000
L40.4 Guttate psoriasis
0.023 0.977 0.000
L40.8 Other psoriasis
0.023 0.977 0.000
L40.2 Acrodermatitis continua
0.022 0.978 0.000
L40.1 Generalised pustular psoriasis
0.022 0.978 0.000
F10 Mental and behavioural disorders due to use of alcohol
0.022 0.978 0.000
L40.3 Pustulosis palmaris et plantaris
0.021 0.979 0.000
L40.5 Arthropathic psoriasis
0.020 0.980 0.000
F10.0 Acute intoxication
0.018 0.982 0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device
0.018 0.982 0.000
F10.9 Unspecified mental and behavioural disorder
0.017 0.983 0.000
F10.5 Psychotic disorder
0.017 0.983 0.000
F10.6 Amnesic syndrome
0.017 0.983 0.000
F10.7 Residual and late-onset psychotic disorder
0.017 0.983 0.000
F10.3 Withdrawal state
0.016 0.984 0.000
F10.8 Other mental and behavioural disorders
0.016 0.984 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.016 0.984 0.000
L40-L45 Papulosquamous disorders
0.015 0.985 0.000
F10.4 Withdrawal state with delirium
0.015 0.985 0.000
M06.9 Rheumatoid arthritis, unspecified
0.013 0.987 0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.012 0.988 0.000
L42 Pityriasis rosea
0.011 0.989 0.000
L44 Other papulosquamous disorders
0.011 0.989 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.011 0.989 0.000
L43 Lichen planus
0.011 0.989 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.011 0.989 0.000
L41 Parapsoriasis
0.011 0.989 0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.011 0.989 0.000
F10.1 Harmful use
0.010 0.990 0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.000 0.990 0.010
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.010 0.990 0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.010 0.990 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.010 0.990 0.000
M06 Other rheumatoid arthritis
0.010 0.990 0.000
K90-K93 Other diseases of the digestive system
0.000 0.990 0.010
M06.98 Rheumatoid arthritis, unspecified (Other)
0.010 0.990 0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.010 0.990 0.000
K70 Alcoholic liver disease
0.010 0.990 0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.009 0.991 0.000
F11 Mental and behavioural disorders due to use of opioids
0.009 0.991 0.000
M06.0 Seronegative rheumatoid arthritis
0.009 0.991 0.000
K70.1 Alcoholic hepatitis
0.009 0.991 0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.009 0.991 0.000
K70.4 Alcoholic hepatic failure
0.009 0.991 0.000
L44.0 Pityriasis rubra pilaris
0.008 0.991 0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.008 0.991 0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.009 0.991 0.000
F12 Mental and behavioural disorders due to use of cannabinoids
0.008 0.991 0.000
L43.8 Other lichen planus
0.008 0.992 0.000
F14 Mental and behavioural disorders due to use of cocaine
0.008 0.992 0.000
K70.0 Alcoholic fatty liver
0.008 0.992 0.000
L44.9 Papulosquamous disorder, unspecified
0.008 0.992 0.000
L44.8 Other specified papulosquamous disorders
0.008 0.992 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.008 0.992 0.000
L44.3 Lichen ruber moniliformis
0.008 0.992 0.000
L44.2 Lichen striatus
0.008 0.992 0.000
L44.1 Lichen nitidus
0.008 0.992 0.000
L43.9 Lichen planus, unspecified
0.008 0.992 0.000
F18 Mental and behavioural disorders due to use of volatile solvents
0.008 0.992 0.000
F16 Mental and behavioural disorders due to use of hallucinogens
0.008 0.992 0.000
K70.3 Alcoholic cirrhosis of liver
0.008 0.992 0.000
L43.3 Subacute (active) lichen planus
0.008 0.992 0.000
L43.2 Lichenoid drug reaction
0.008 0.992 0.000
L43.1 Bullous lichen planus
0.008 0.992 0.000
M23.8 Other internal derangements of knee
0.000 0.992 0.008
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.008 0.992 0.000
L41.9 Parapsoriasis, unspecified
0.008 0.992 0.000
L41.8 Other parapsoriasis
0.008 0.992 0.000
L41.5 Retiform parapsoriasis
0.008 0.992 0.000
L41.4 Large plaque parapsoriasis
0.008 0.992 0.000
L41.3 Small plaque parapsoriasis
0.008 0.992 0.000
L41.2 Lymphomatoid papulosis
0.008 0.992 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.008 0.992 0.000
L41.1 Pityriasis lichenoides chronica
0.008 0.992 0.000
K70.9 Alcoholic liver disease, unspecified
0.008 0.992 0.000
M06.3 Rheumatoid nodule
0.008 0.992 0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)
0.000 0.992 0.008
K90 Intestinal malabsorption
0.000 0.992 0.008
L43.0 Hypertrophic lichen planus
0.008 0.992 0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.008 0.992 0.000
F11.2 Dependence syndrome
0.008 0.992 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.008 0.992 0.000
M06.8 Other specified rheumatoid arthritis
0.007 0.992 0.000
M06.1 Adult-onset Still's disease
0.007 0.992 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.993 0.007
M06.2 Rheumatoid bursitis
0.007 0.993 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.007 0.993 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.993 0.007
F11.1 Harmful use
0.007 0.993 0.000
M06.06 Seronegative rheumatoid arthritis (Lower leg)
0.007 0.993 0.000
K70.2 Alcoholic fibrosis and sclerosis of liver
0.007 0.993 0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.007 0.993 0.000
F11.3 Withdrawal state
0.007 0.993 0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.007 0.993 0.000
M06.4 Inflammatory polyarthropathy
0.007 0.993 0.000
K76.9 Liver disease, unspecified
0.007 0.993 0.000
Y42.7 Androgens and anabolic congeners
0.007 0.993 0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.007 0.993 0.000
F11.9 Unspecified mental and behavioural disorder
0.007 0.993 0.000
F11.8 Other mental and behavioural disorders
0.007 0.993 0.000
F11.7 Residual and late-onset psychotic disorder
0.007 0.993 0.000
F11.6 Amnesic syndrome
0.007 0.993 0.000
F11.5 Psychotic disorder
0.007 0.993 0.000
F11.4 Withdrawal state with delirium
0.007 0.993 0.000
Y42.5 Other oestrogens and progestogens
0.007 0.993 0.000
F11.0 Acute intoxication
0.007 0.993 0.000
M06.08 Seronegative rheumatoid arthritis (Other)
0.007 0.993 0.000
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.007 0.993 0.000
M06.04 Seronegative rheumatoid arthritis (Hand)
0.007 0.993 0.000
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.007 0.993 0.000
M23.80 Other internal derangements of knee (Multiple sites)
0.000 0.993 0.007
F19.1 Harmful use
0.007 0.993 0.000
F12.2 Dependence syndrome
0.007 0.993 0.000
F19.2 Dependence syndrome
0.007 0.993 0.000
F19.5 Psychotic disorder
0.007 0.993 0.000
F17 Mental and behavioural disorders due to use of tobacco
0.007 0.993 0.000
F12.0 Acute intoxication
0.006 0.993 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.007 0.993 0.000
F14.2 Dependence syndrome
0.006 0.993 0.000
F19.9 Unspecified mental and behavioural disorder
0.006 0.993 0.000
F19.8 Other mental and behavioural disorders
0.006 0.993 0.000
F19.7 Residual and late-onset psychotic disorder
0.006 0.993 0.000
F19.6 Amnesic syndrome
0.006 0.993 0.000
F19.4 Withdrawal state with delirium
0.006 0.993 0.000
F19.0 Acute intoxication
0.006 0.993 0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.006 0.993 0.000
F12.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F12.8 Other mental and behavioural disorders
0.006 0.994 0.000
F12.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F12.6 Amnesic syndrome
0.006 0.994 0.000
F12.4 Withdrawal state with delirium
0.006 0.994 0.000
F12.3 Withdrawal state
0.006 0.994 0.000
F12.1 Harmful use
0.006 0.994 0.000
F14.1 Harmful use
0.006 0.994 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.994 0.006
F14.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F14.8 Other mental and behavioural disorders
0.006 0.994 0.000
F14.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F14.6 Amnesic syndrome
0.006 0.994 0.000
F14.5 Psychotic disorder
0.006 0.994 0.000
F14.4 Withdrawal state with delirium
0.006 0.994 0.000
F14.3 Withdrawal state
0.006 0.994 0.000
F14.0 Acute intoxication
0.006 0.994 0.000
Z87.0 Personal history of diseases of the respiratory system
0.006 0.994 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.006 0.994 0.000
M23.87 Other internal derangements of knee (Capsular ligament)
0.000 0.994 0.006
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)
0.000 0.994 0.006
F19.3 Withdrawal state
0.006 0.994 0.000
F16.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F16.8 Other mental and behavioural disorders
0.006 0.994 0.000
F16.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F16.6 Amnesic syndrome
0.006 0.994 0.000
F16.5 Psychotic disorder
0.006 0.994 0.000
F16.4 Withdrawal state with delirium
0.006 0.994 0.000
F16.3 Withdrawal state
0.006 0.994 0.000
F16.2 Dependence syndrome
0.006 0.994 0.000
F16.1 Harmful use
0.006 0.994 0.000
F16.0 Acute intoxication
0.006 0.994 0.000
F18.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F18.8 Other mental and behavioural disorders
0.006 0.994 0.000
F18.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F18.6 Amnesic syndrome
0.006 0.994 0.000
F18.5 Psychotic disorder
0.006 0.994 0.000
F18.4 Withdrawal state with delirium
0.006 0.994 0.000
F18.3 Withdrawal state
0.006 0.994 0.000
F18.2 Dependence syndrome
0.006 0.994 0.000
F18.1 Harmful use
0.006 0.994 0.000
F18.0 Acute intoxication
0.006 0.994 0.000
M06.32 Rheumatoid nodule (Upper arm)
0.006 0.994 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.006 0.994 0.000
M06.36 Rheumatoid nodule (Lower leg)
0.006 0.994 0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)
0.000 0.994 0.006
F13.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F13.8 Other mental and behavioural disorders
0.006 0.994 0.000
F13.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F13.6 Amnesic syndrome
0.006 0.994 0.000
F13.5 Psychotic disorder
0.006 0.994 0.000
F13.4 Withdrawal state with delirium
0.006 0.994 0.000
F13.2 Dependence syndrome
0.006 0.994 0.000
F13.0 Acute intoxication
0.006 0.994 0.000
F12.5 Psychotic disorder
0.006 0.994 0.000
F13.3 Withdrawal state
0.006 0.994 0.000
M06.37 Rheumatoid nodule (Ankle and foot)
0.006 0.994 0.000
K76 Other diseases of liver
0.006 0.994 0.000
F13.1 Harmful use
0.006 0.994 0.000
M06.39 Rheumatoid nodule (Site unspecified)
0.006 0.994 0.000
M06.38 Rheumatoid nodule (Other)
0.006 0.994 0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.006 0.994 0.000
M06.31 Rheumatoid nodule (Shoulder region)
0.006 0.994 0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)
0.000 0.994 0.006
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.000 0.994 0.006
M06.89 Other specified rheumatoid arthritis (Site unspecified)
0.006 0.994 0.000
M06.33 Rheumatoid nodule (Forearm)
0.006 0.994 0.000
F15.9 Unspecified mental and behavioural disorder
0.006 0.994 0.000
F15.8 Other mental and behavioural disorders
0.006 0.994 0.000
F15.7 Residual and late-onset psychotic disorder
0.006 0.994 0.000
F15.6 Amnesic syndrome
0.006 0.994 0.000
F15.5 Psychotic disorder
0.006 0.994 0.000
F15.4 Withdrawal state with delirium
0.006 0.994 0.000
F15.3 Withdrawal state
0.006 0.994 0.000
F15.2 Dependence syndrome
0.006 0.994 0.000
K90.3 Pancreatic steatorrhoea
0.000 0.994 0.006
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.994 0.006
K90.1 Tropical sprue
0.000 0.994 0.006
Y42.2 Antithyroid drugs
0.006 0.994 0.000
K70-K77 Diseases of liver
0.006 0.994 0.000
M06.10 Adult-onset Still's disease (Multiple sites)
0.006 0.994 0.000
D23.5 Skin of trunk
0.000 0.994 0.006
F15.1 Harmful use
0.006 0.994 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.006 0.994 0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.000 0.994 0.006
M06.88 Other specified rheumatoid arthritis (Other)
0.005 0.994 0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)
0.005 0.994 0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)
0.005 0.994 0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)
0.005 0.994 0.000
M06.84 Other specified rheumatoid arthritis (Hand)
0.005 0.994 0.000
M06.83 Other specified rheumatoid arthritis (Forearm)
0.005 0.994 0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)
0.005 0.994 0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)
0.005 0.994 0.000
Y42.4 Oral contraceptives
0.006 0.994 0.000
M06.18 Adult-onset Still's disease (Other)
0.005 0.994 0.000
M06.17 Adult-onset Still's disease (Ankle and foot)
0.005 0.994 0.000
M06.16 Adult-onset Still's disease (Lower leg)
0.005 0.994 0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.005 0.994 0.000
M06.14 Adult-onset Still's disease (Hand)
0.005 0.994 0.000
M06.13 Adult-onset Still's disease (Forearm)
0.005 0.994 0.000
M06.12 Adult-onset Still's disease (Upper arm)
0.005 0.994 0.000
M06.11 Adult-onset Still's disease (Shoulder region)
0.005 0.994 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.006 0.994 0.000
M06.29 Rheumatoid bursitis (Site unspecified)
0.005 0.994 0.000
M06.28 Rheumatoid bursitis (Other)
0.005 0.994 0.000
M06.27 Rheumatoid bursitis (Ankle and foot)
0.005 0.994 0.000
M06.26 Rheumatoid bursitis (Lower leg)
0.005 0.994 0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.005 0.994 0.000
M06.24 Rheumatoid bursitis (Hand)
0.005 0.994 0.000
M06.23 Rheumatoid bursitis (Forearm)
0.005 0.994 0.000
M06.22 Rheumatoid bursitis (Upper arm)
0.005 0.994 0.000
M06.21 Rheumatoid bursitis (Shoulder region)
0.005 0.994 0.000
M06.20 Rheumatoid bursitis (Multiple sites)
0.005 0.994 0.000
M06.34 Rheumatoid nodule (Hand)
0.005 0.994 0.000
Y52 Agents primarily affecting the cardiovascular system
0.006 0.994 0.000
M06.19 Adult-onset Still's disease (Site unspecified)
0.005 0.994 0.000
F15.0 Acute intoxication
0.005 0.994 0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.994 0.005
K93.1 Megacolon in Chagas' disease
0.000 0.994 0.005
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.994 0.005
Y49 Psychotropic drugs, not elsewhere classified
0.005 0.994 0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.005 0.994 0.000
Y48 Anaesthetics and therapeutic gases
0.005 0.994 0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)
0.005 0.994 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.995 0.000
Y42.1 Thyroid hormones and substitutes
0.005 0.995 0.000
S72.10 Pertrochanteric fracture (closed)
0.005 0.995 0.000
Y44 Agents primarily affecting blood constituents
0.005 0.995 0.000
M06.48 Inflammatory polyarthropathy (Other)
0.005 0.995 0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.005 0.995 0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.005 0.995 0.000
M06.44 Inflammatory polyarthropathy (Hand)
0.005 0.995 0.000
M06.43 Inflammatory polyarthropathy (Forearm)
0.005 0.995 0.000
M06.42 Inflammatory polyarthropathy (Upper arm)
0.005 0.995 0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.005 0.995 0.000
K76.7 Hepatorenal syndrome
0.005 0.995 0.000
M06.46 Inflammatory polyarthropathy (Lower leg)
0.005 0.995 0.000
K90.8 Other intestinal malabsorption
0.000 0.995 0.005
Y45.2 Propionic acid derivatives
0.005 0.995 0.000
Y42.9 Other and unspecified hormone antagonists
0.005 0.995 0.000
F17.0 Acute intoxication
0.005 0.995 0.000
Y57 Other and unspecified drugs and medicaments
0.005 0.995 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.005 0.995 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.005 0.995 0.000
Y58 Bacterial vaccines
0.005 0.995 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.005 0.995 0.000
F17.8 Other mental and behavioural disorders
0.005 0.995 0.000
F17.7 Residual and late-onset psychotic disorder
0.005 0.995 0.000
F17.6 Amnesic syndrome
0.005 0.995 0.000
F17.5 Psychotic disorder
0.005 0.995 0.000
F17.4 Withdrawal state with delirium
0.005 0.995 0.000
K76.8 Other specified diseases of liver
0.005 0.995 0.000
Y45.8 Other analgesics and antipyretics
0.005 0.995 0.000
K72 Hepatic failure, not elsewhere classified
0.005 0.995 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.005 0.995 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.005 0.995 0.000
F17.2 Dependence syndrome
0.005 0.995 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.005 0.995 0.000
F17.9 Unspecified mental and behavioural disorder
0.005 0.995 0.000
Y45.5 4-Aminophenol derivatives
0.005 0.995 0.000
Y45.1 Salicylates
0.005 0.995 0.000
F17.3 Withdrawal state
0.005 0.995 0.000
Y45.4 Antirheumatics
0.005 0.995 0.000
K73 Chronic hepatitis, not elsewhere classified
0.005 0.995 0.000
Y43 Primarily systemic agents
0.005 0.995 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.005 0.995 0.000
K76.3 Infarction of liver
0.005 0.995 0.000
Y45.0 Opioids and related analgesics
0.005 0.995 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.005 0.995 0.000
K76.1 Chronic passive congestion of liver
0.005 0.995 0.000
Y59 Other and unspecified vaccines and biological substances
0.005 0.995 0.000
Y48.3 Local anaesthetics
0.005 0.995 0.000
Y49.2 Other and unspecified antidepressants
0.005 0.995 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.005 0.995 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.005 0.995 0.000
Y40 Systemic antibiotics
0.005 0.995 0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.004 0.995 0.000
K76.5 Hepatic veno-occlusive disease
0.005 0.995 0.000
K76.4 Peliosis hepatis
0.005 0.995 0.000
K76.2 Central haemorrhagic necrosis of liver
0.005 0.995 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.995 0.000
Y52.1 Calcium-channel blockers
0.005 0.995 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.004 0.995 0.000
Y49.5 Other antipsychotics and neuroleptics
0.004 0.995 0.000
K72.9 Hepatic failure, unspecified
0.004 0.995 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.004 0.995 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.004 0.996 0.000
Y41.5 Antiviral drugs
0.004 0.996 0.000
Y48.4 Anaesthetic, unspecified
0.004 0.996 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.004 0.996 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.004 0.996 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.004 0.996 0.000
Y57.9 Drug or medicament, unspecified
0.004 0.996 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
K71 Toxic liver disease
0.004 0.996 0.000
Y52.7 Peripheral vasodilators
0.004 0.996 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.004 0.996 0.000
Y41.4 Anthelminthics
0.004 0.996 0.000
Y41.3 Other antiprotozoal drugs
0.004 0.996 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.004 0.996 0.000
Y46.2 Hydantoin derivatives
0.004 0.996 0.000
Y43.1 Antineoplastic antimetabolites
0.004 0.996 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.004 0.996 0.000
K77 Liver disorders in diseases classified elsewhere
0.004 0.996 0.000
Y44.6 Natural blood and blood products
0.004 0.996 0.000
Y41.1 Antimycobacterial drugs
0.004 0.996 0.000
Y49.9 Psychotropic drug, unspecified
0.004 0.996 0.000
Y49.7 Psychostimulants with abuse potential
0.004 0.996 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.004 0.996 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.004 0.996 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.004 0.996 0.000
Y44.5 Thrombolytic drugs
0.004 0.996 0.000
K73.9 Chronic hepatitis, unspecified
0.004 0.996 0.000
Y48.5 Therapeutic gases
0.004 0.996 0.000
Y48.1 Parenteral anaesthetics
0.004 0.996 0.000
Y48.0 Inhaled anaesthetics
0.004 0.996 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.004 0.996 0.000
Y44.2 Anticoagulants
0.004 0.996 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.004 0.996 0.000
Y57.8 Other drugs and medicaments
0.004 0.996 0.000
Y57.6 Other diagnostic agents
0.004 0.996 0.000
Y41.0 Sulphonamides
0.004 0.996 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.004 0.996 0.000
Y44.7 Plasma substitutes
0.004 0.996 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.004 0.996 0.000
Y48.2 Other and unspecified general anaesthetics
0.004 0.996 0.000
K72.1 Chronic hepatic failure
0.004 0.996 0.000
S72.1 Pertrochanteric fracture
0.004 0.996 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.004 0.996 0.000
Y40.9 Systemic antibiotic, unspecified
0.004 0.996 0.000
K76.6 Portal hypertension
0.004 0.996 0.000
Y46.5 Valproic acid
0.004 0.996 0.000
Y57.7 Vitamins, not elsewhere classified
0.004 0.996 0.000
Y57.4 Pharmaceutical excipients
0.004 0.996 0.000
Y57.3 Alcohol deterrents
0.004 0.996 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.004 0.996 0.000
Y57.1 Lipotropic drugs
0.004 0.996 0.000
Y57.0 Appetite depressants [anorectics]
0.004 0.996 0.000
Y58.0 BCG vaccine
0.004 0.996 0.000
Y46.7 Anti-Parkinsonism drugs
0.004 0.996 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.004 0.996 0.000
K73.8 Other chronic hepatitis, not elsewhere classified
0.004 0.996 0.000
Y46.8 Antispasticity drugs
0.004 0.996 0.000
Y46.3 Deoxybarbiturates
0.004 0.996 0.000
Y46.1 Oxazolidinediones
0.004 0.996 0.000
Y46.0 Succinimides
0.004 0.996 0.000
Y55.0 Oxytocic drugs
0.004 0.996 0.000
Y58.9 Other and unspecified bacterial vaccines
0.004 0.996 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.004 0.996 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.004 0.996 0.000
Y58.5 Diphtheria vaccine
0.004 0.996 0.000
Y58.4 Tetanus vaccine
0.004 0.996 0.000
Y58.3 Plague vaccine
0.004 0.996 0.000
Y58.2 Cholera vaccine
0.004 0.996 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.004 0.996 0.000
Y47.1 Benzodiazepines
0.004 0.996 0.000
Y43.0 Antiallergic and antiemetic drugs
0.004 0.996 0.000
Y55.4 Expectorants
0.004 0.996 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.004 0.996 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.004 0.996 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.004 0.996 0.000
Y47.4 Bromine compounds
0.004 0.996 0.000
Y47.3 Paraldehyde
0.004 0.996 0.000
Y47.2 Chloral derivatives
0.004 0.996 0.000
Y47.0 Barbiturates, not elsewhere classified
0.004 0.996 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.004 0.996 0.000
Y55.5 Anticommon cold drugs
0.004 0.996 0.000
Y55.3 Antitussives
0.004 0.996 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.004 0.996 0.000
S61.1 Open wound of finger(s) with damage to nail
0.004 0.996 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.004 0.996 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.004 0.996 0.000
Y50.9 Central nervous system stimulant, unspecified
0.004 0.996 0.000
Y50.8 Other central nervous system stimulants
0.004 0.996 0.000
Y50.1 Opioid receptor antagonists
0.004 0.996 0.000
Y50.0 Analeptics
0.004 0.996 0.000
Y40.4 Tetracyclines
0.004 0.996 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.004 0.996 0.000
Y40.5 Aminoglycosides
0.004 0.996 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.004 0.996 0.000
Y46.4 Iminostilbenes
0.004 0.996 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.004 0.996 0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified
0.004 0.996 0.000
K73.0 Chronic persistent hepatitis, not elsewhere classified
0.004 0.996 0.000
Y43.9 Primarily systemic agent, unspecified
0.004 0.996 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.004 0.996 0.000
Y43.6 Enzymes, not elsewhere classified
0.004 0.996 0.000
Y43.5 Acidifying and alkalising agents
0.004 0.996 0.000
R00.1 Bradycardia, unspecified
0.004 0.996 0.000
Z46.6 Fitting and adjustment of urinary device
0.004 0.996 0.000
Y40.6 Rifamycins
0.004 0.996 0.000
Y56.3 Emollients, demulcents and protectants
0.003 0.996 0.000
Y59.9 Vaccine or biological substance, unspecified
0.003 0.996 0.000
Y59.8 Other specified vaccines and biological substances
0.003 0.996 0.000
Y59.2 Protozoal vaccines
0.003 0.996 0.000
Y59.1 Rickettsial vaccines
0.003 0.996 0.000
Y59.0 Viral vaccines
0.003 0.996 0.000
Y46.6 Other and unspecified antiepileptics
0.003 0.996 0.000
Y40.2 Chloramphenicol group
0.003 0.996 0.000
Y56.9 Topical agent, unspecified
0.003 0.996 0.000
Y56.8 Other topical agents
0.003 0.996 0.000
Y56.7 Dental drugs, topically applied
0.003 0.996 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.003 0.996 0.000
Y56.5 Ophthalmological drugs and preparations
0.003 0.996 0.000
Y56.2 Local astringents and local detergents
0.003 0.996 0.000
Y56.1 Antipruritics
0.003 0.996 0.000
Z98.0 Intestinal bypass and anastomosis status
0.000 0.996 0.004
Y40.1 Cefalosporins and other -lactam antibiotics
0.003 0.996 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.003 0.996 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.003 0.996 0.000
K90.0 Coeliac disease
0.000 0.996 0.004
Y57.5 X-ray contrast media
0.003 0.996 0.000
Y43.2 Antineoplastic natural products
0.003 0.996 0.000
Y40.7 Antifungal antibiotics, systemically used
0.003 0.996 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.996 0.000
I46.9 Cardiac arrest, unspecified
0.004 0.996 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.003 0.996 0.000
Y53.2 Stimulant laxatives
0.003 0.996 0.000
K75 Other inflammatory liver diseases
0.003 0.996 0.000
F17.1 Harmful use
0.004 0.996 0.000
K72.0 Acute and subacute hepatic failure
0.003 0.997 0.000
Y40.3 Macrolides
0.003 0.997 0.000
Y43.4 Immunosuppressive agents
0.003 0.997 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.003 0.997 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.003 0.997 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.003 0.997 0.000
Y51.0 Anticholinesterase agents
0.003 0.997 0.000
Y59.3 Immunoglobulin
0.003 0.997 0.000
K71.0 Toxic liver disease with cholestasis
0.003 0.997 0.000
K77.8 Liver disorders in other diseases classified elsewhere
0.003 0.997 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.003 0.997 0.000
Y53.7 Emetics
0.003 0.997 0.000
Y53.5 Digestants
0.003 0.997 0.000
Y53.0 Histamine H2-receptor antagonists
0.003 0.997 0.000
Y54.0 Mineralocorticoids
0.003 0.997 0.000
K71.8 Toxic liver disease with other disorders of liver
0.003 0.997 0.000
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver
0.003 0.997 0.000
K71.5 Toxic liver disease with chronic active hepatitis
0.003 0.997 0.000
K71.4 Toxic liver disease with chronic lobular hepatitis
0.003 0.997 0.000
K71.3 Toxic liver disease with chronic persistent hepatitis
0.003 0.997 0.000
K71.2 Toxic liver disease with acute hepatitis
0.003 0.997 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.003 0.997 0.000
Y53.6 Antidiarrhoeal drugs
0.003 0.997 0.000
Y53.3 Saline and osmotic laxatives
0.003 0.997 0.000
K71.9 Toxic liver disease, unspecified
0.003 0.997 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.003 0.997 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.003 0.997 0.000
Y53.4 Other laxatives
0.003 0.997 0.000
Y54.5 Other diuretics
0.003 0.997 0.000
Y54.4 Loop [high-ceiling] diuretics
0.003 0.997 0.000
K71.1 Toxic liver disease with hepatic necrosis
0.003 0.997 0.000
K71.6 Toxic liver disease with hepatitis, not elsewhere classified
0.003 0.997 0.000
Y54.9 Mineral salts, not elsewhere classified
0.003 0.997 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.003 0.997 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.003 0.997 0.000
K73.2 Chronic active hepatitis, not elsewhere classified
0.003 0.997 0.000
S72.11 Pertrochanteric fracture (open)
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.